Natera, Inc. is 8.1x more valuable than VERACYTE, INC. by market capitalization ($31.01 B vs $3.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCYT | NTRA |
|---|---|---|
| Market cap | $3.84 B | $31.01 B |
| US-listed rank | #1603 | #451 |
| Revenue (latest FY) | $517.14M | $2.31B |
| Net income (latest FY) | $66.40M | -$208.16M |
| Net margin | 12.8% | -9.0% |
| P/E (trailing FY) | 57.9 | - |
| SEC filings | 1,126 | 1,695 |
Natera, Inc. is 8.1x more valuable than VERACYTE, INC. by market capitalization ($31.01 B vs $3.84 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while Natera, Inc. reported $2.31B.
Full pages: VERACYTE, INC. and Natera, Inc., or browse the full rankings.